Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AgeX Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AGE
American
2834
https://www.agexinc.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AgeX Therapeutics Inc
AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
- Mar 22nd, 2024 9:27 pm
Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer
- Nov 17th, 2023 1:00 pm
AgeX Therapeutics Reports Third Quarter 2023 Financial Results
- Nov 14th, 2023 9:05 pm
Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
- Aug 30th, 2023 11:00 am
AgeX Therapeutics Reports Second Quarter 2023 Financial Results
- Aug 14th, 2023 8:05 pm
AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock
- Jul 24th, 2023 10:28 pm
AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock
- Jul 21st, 2023 9:32 pm
AgeX Therapeutics Announces Appeal of NYSE American Determination
- May 23rd, 2023 8:05 pm
AgeX Therapeutics Reports First Quarter 2023 Financial Results
- May 12th, 2023 8:05 pm
AgeX Therapeutics Receives Stock Exchange Deficiency Letter
- Apr 26th, 2023 8:05 pm
AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results
- Mar 31st, 2023 8:05 pm
Scroll